Filter posts

Drug Importation and Its Dangerous Side Effects

Writing for the National Review, Sally Pipes of the Pacific Research Institute authors a stark …

BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs

This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the …

Dr. Jeremy Levin on BIO’s Path to an Addiction-Free America

This week, Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics and Chair of BIO’s …

ICYMI: Access to Medication-Assisted Treatment Critical in Fighting Opioid Addiction

Opioid abuse and addiction in America has reached epidemic heights. The Centers for Disease Control …

60 Minutes Shines Spotlight on the Power and Promise of CRISPR

On Sunday night, 60 Minutes ran a captivating segment on the promise and possibilities of …

Vaccines: Vital in fighting antimicrobial resistance

In recognition of BIO’s 25th Anniversary, each month we are celebrating historical milestones in biotech. …

The Latest Good News on Prescription Drug Costs

Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These …

Fact Checking Misleading Claims about Drug Costs

In a series of new blogs, AHIP once again paints drug manufacturers as the culprit …

A New Framework for Evaluating – and Encouraging – Industry’s IP-Sharing Activities for Global...

The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to …

One Health: Biotechnology Sector Ready to Act

Globalization has changed our models of disease. Emerging health threats throughout the world have the …